[Advances in the therapy of cardiac failure].
Pérez-Villa
Félix
F
Unidad de Insuficiencia Cardíaca, Hospital Clínic de Barcelona, Barcelona, Spain.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists; D002304:Cardiac Pacing, Artificial; D002317:Cardiovascular Agents / Q000627:therapeutic use; D017690:Cell Transplantation; D065128:Endothelin Receptor Antagonists; D006333:Heart Failure / Q000188:drug therapy* / Q000601:surgery*; D016027:Heart Transplantation; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists; D032446:Myoblasts / Q000637:transplantation; D018124:Receptors, Tumor Necrosis Factor / Q000037:antagonists & inhibitors
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D002317:Cardiovascular Agents; D065128:Endothelin Receptor Antagonists; D000451:Mineralocorticoid Receptor Antagonists; D018124:Receptors, Tumor Necrosis Factor